Condition: Chronic Pseudomonas Aeruginosa Infection · Cystic Fibrosis (CF) · Sponsor: BiomX Ltd
The goal of this Phase 2b clinical trial is to see if nebulized phage (BX004) can treat chronic Pseudomonas aeruginosa (PsA) lung infection in CF subjects. The primary goal is to see if 8 weeks of twice daily BX004 can reduce the amount of PsA in the sputum compared to placebo (on top of background CF therapy).
This description comes directly from the study's public registry record.
Urania Rappo, MD · 1-617-256-2625 · uraniar@biomx.com
Always discuss trial participation with your own doctor first.
| University of Alabama at Birmingham | Birmingham, Alabama, United States | Recruiting |
| Providence Alaska Medical Center | Anchorage, Alaska, United States | Not Yet Recruiting |
| University of Arkansas for Medical Sciences | Little Rock, Arkansas, United States | Not Yet Recruiting |
| Stanford University | Palo Alto, California, United States | Not Yet Recruiting |
| University of California San Francisco | San Francisco, California, United States | Recruiting |
| National Jewish Health | Denver, Colorado, United States | Recruiting |
| Joe DiMaggio Children's Health | Hollywood, Florida, United States | Not Yet Recruiting |
| Central Florida Pulmonary Group | Orlando, Florida, United States | Recruiting |
| Avanza Medical Center | Pensacola, Florida, United States | Recruiting |
| Rutgers, Robert Wood Johnson Medical School | New Brunswick, New Jersey, United States | Recruiting |
| New York Medical College | Hawthorne, New York, United States | Recruiting |
| Northwell Health | New York, New York, United States | Recruiting |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06998043